Literature DB >> 27113697

Continuous Renal Replacement Therapy for the Management of Acid-Base and Electrolyte Imbalances in Acute Kidney Injury.

Lenar Yessayan1, Jerry Yee2, Stan Frinak2, Balazs Szamosfalvi2.   

Abstract

Continuous renal replacement therapy (CRRT) is used to manage electrolyte and acid-base imbalances in critically ill patients with acute kidney injury. Although a standard solution and prescription is acceptable in most clinical circumstances, specific disorders may require a tailored approach such as adjusting fluid composition, regulating CRRT dose, and using separate intravenous infusions to mitigate and correct these disturbances. Errors in fluid prescription, compounding, or delivery can be rapidly fatal. This article provides an overview of the principles of acid-base and electrolyte management using CRRT.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acidosis; Alkalosis; CRRT; Hyperkalemia; Hyponatremia

Mesh:

Year:  2016        PMID: 27113697     DOI: 10.1053/j.ackd.2016.02.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  11 in total

Review 1.  Continuous Renal Replacement Therapy: Who, When, Why, and How.

Authors:  Srijan Tandukar; Paul M Palevsky
Journal:  Chest       Date:  2018-09-25       Impact factor: 9.410

2.  Management of Severe Hyponatremia with Continuous Renal Replacement Therapies.

Authors:  Mitchell H Rosner; Michael J Connor
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-20       Impact factor: 8.237

Review 3.  How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.

Authors:  Javier A Neyra; Lenar Yessayan; Melissa L Thompson Bastin; Keith M Wille; Ashita J Tolwani
Journal:  Kidney360       Date:  2020-12-14

4.  Severe Hyponatremia and Continuous Renal Replacement Therapy: Safety and Effectiveness of Low-Sodium Dialysate.

Authors:  Srijan Tandukar; Catherine Kim; Kartik Kalra; Siddharth Verma; Paul M Palevsky; Chethan Puttarajappa
Journal:  Kidney Med       Date:  2020-06-15

5.  Blood purification treatment initiated at the time of sepsis diagnosis effectively attenuates serum HMGB1 upregulation and improves patient prognosis.

Authors:  Shixiang Zheng; Qinyong Weng; Wenwei Wu; Guohua Ding
Journal:  Exp Ther Med       Date:  2017-07-31       Impact factor: 2.447

6.  Impact of protocolized fluid management on electrolyte stability in patients undergoing continuous renal replacement therapy.

Authors:  Song In Baeg; Junseok Jeon; Danbee Kang; Soo Jin Na; Juhee Cho; Kyunga Kim; Jeong Hoon Yang; Chi Ryang Chung; Jung Eun Lee; Wooseong Huh; Gee Young Suh; Yoon-Goo Kim; Dae Joong Kim; Hye Ryoun Jang
Journal:  Front Med (Lausanne)       Date:  2022-08-31

7.  Natraemia variations induced by acute dialysis in critically ill patients: a database study.

Authors:  Gilles Troché; Virginie Laurent; Alexis Ferré; Gwenaelle Jacq; Marine Paul; Sybille Merceron; Stephane Legriel
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

8.  Continuous Renal Replacement Therapy Dosing in the Severely Underweight: A Case Report.

Authors:  Benjamin R Griffin; Sophia Ambruso; Anna Jovanovich; Anip Bansal; Stu Linas; James Dylewski
Journal:  Kidney Med       Date:  2019-06-17

9.  Rapid calcium loss may cause arrhythmia in hemofiltration with regional citrate anticoagulation: a case report.

Authors:  Buyun Wu; Jing Wang; Guang Yang; Changying Xing; Huijuan Mao
Journal:  BMC Nephrol       Date:  2018-06-14       Impact factor: 2.388

10.  Acid base variables predict survival early in the course of treatment with continuous venovenous hemodiafiltration.

Authors:  Rogério da Hora Passos; Juliana Ribeiro Caldas; João Gabriel Rosa Ramos; Paulo Benigno Pena Batista; Danilo Teixeira Noritomi; Nelson Akamine; Marcelino de Souza Durão Junior; Bento Fortunato Cardoso Dos Santos; Virgilio Gonçalves Pereira Junior; Julio Cesar Martins Monte; Marcelo Costa Batista; Oscar Fernando Pavão Dos Santos
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.